- Home
- COSM vs ANTX Comparison
COSM vs ANTX Comparison
Compare COSM & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSM
- ANTX
- Stock Information
- Founded
- COSM 2009
- ANTX 2017
- Country
- COSM United States
- ANTX United States
- Employees
- COSM N/A
- ANTX N/A
- Industry
- COSM Other Pharmaceuticals
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- COSM Health Care
- ANTX Health Care
- Exchange
- COSM Nasdaq
- ANTX Nasdaq
- Market Cap
- COSM 32.3M
- ANTX 34.4M
- IPO Year
- COSM 2013
- ANTX 2022
- Fundamental
- Price
- COSM $0.81
- ANTX $1.23
- Analyst Decision
- COSM
- ANTX Buy
- Analyst Count
- COSM 0
- ANTX 2
- Target Price
- COSM N/A
- ANTX $2.00
- AVG Volume (30 Days)
- COSM 972.4K
- ANTX 64.6K
- Earning Date
- COSM 11-14-2025
- ANTX 11-12-2025
- Dividend Yield
- COSM N/A
- ANTX N/A
- EPS Growth
- COSM N/A
- ANTX N/A
- EPS
- COSM N/A
- ANTX N/A
- Revenue
- COSM $55,093,442.00
- ANTX N/A
- Revenue This Year
- COSM $28.14
- ANTX N/A
- Revenue Next Year
- COSM N/A
- ANTX N/A
- P/E Ratio
- COSM N/A
- ANTX N/A
- Revenue Growth
- COSM N/A
- ANTX N/A
- 52 Week Low
- COSM $0.28
- ANTX $0.98
- 52 Week High
- COSM $1.32
- ANTX $1.68
- Technical
- Relative Strength Index (RSI)
- COSM 35.10
- ANTX 48.89
- Support Level
- COSM $0.98
- ANTX $1.14
- Resistance Level
- COSM $1.04
- ANTX $1.36
- Average True Range (ATR)
- COSM 0.11
- ANTX 0.07
- MACD
- COSM -0.03
- ANTX 0.00
- Stochastic Oscillator
- COSM 8.26
- ANTX 43.48
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.